Çocukluk Çağında Uyku Bozukluklarının Klinik Değerlendirilmesi: Polisomnografi Temelli Çalışma

Öz

Obstrüktif uyku apne sendromu (OSAS) pediatrik popülasyonda giderek daha fazla tanınmaktadır. Bazı pulmoner ve endokrinolojik bozuklukların OSAS'tan etkilenebileceği veya OSAS'ın varlığı nedeniyle daha şiddetli bir klinik seyir gösterebileceği dikkate alınmalıdır. Bu çalışmada pediatrik yaş grubunda polisomnografi uygulaması, kronik komorbiditelerde özellikle endokrinolojik ve solunum yolu hastalıklarında uyku bozukluklarının tanısı konulması, tedavi edilmesi ve hastaların sağlıklı gelişimi için yaşam kalitesi iyileştirme önemlerinin vurgulanması amaçlanmıştır. Bursa Uludağ Tıp Fakültesi Nöroloji Anabilim Dalı, Uyku Bozukluklarının Birimi, Ocak 2020 ile Nisan 2025 tarihleri arasında yapılan PSG kayıtları geriye dönük olarak incelendi. Yapılan PSG kayıtları arasında Pediatrik Endokrinoloji ve Metabolizma, Pediatrik Göğüs hastalıkları ve Pediatrik İmmünoloji ve Alerji bölümlerinden yönlendirilen hastalar araştırıldı. Bizim merkezde yapılan PSG sonuçlarında endokrinolojik veya solunumsal hastalığı eşlik eden çocuklarda OSAS’ın görülme sıklığı normal pediatrik popülasyonuna göre daha yüksek (%25.7 vs %3), ortalama yaşı daha büyük (7yaş vs 4yaş) saptanmıştır. Bu hastalar ve normal çocuklarda uyku bozuklukları görülme oranı benzer (%54,4 vs >%50), santral apne sıklığı ise literatürden farksız saptanmıştır (%2.9). Uyku bozukluğu olan hastalarda cinsiyet farkı görülmemiştir.

Anahtar Kelimeler

• Uyku Bozuklukları
• Çocukluk Çağı
• Polisomnografi
• Endokrinolojik Bozukluklar
• Solunum Hastalıkları

Clinical Evaluation of Sleep Disorders in Childhood: A Polysomnography-Based Study

Öz

Obstructive Sleep Apnoea Syndrome (OSAS) is increasingly recognised in the paediatric population. It is important to consider that certain pulmonary and endocrinological disorders may be influenced by OSAS or exhibit a more severe clinical course due to the presence of OSAS. This study aims to highlight the application of polysomnography in the paediatric population, particularly in the diagnosis and treatment of sleep disorders associated with chronic comorbidities—most notably endocrinological and respiratory conditions—and to emphasise the importance of improving quality of life measures to support healthy development in affected children. Polysomnography (PSG) recordings obtained between January 2020 and April 2025 at the Sleep Disorders Unit of the Department of Neurology, Faculty of Medicine, Bursa Uludag University, were retrospectively reviewed. Among these PSG records, patients referred from the Departments of Paediatric Endocrinology and Metabolism, Paediatric Pulmonology, and Paediatric Immunology and Allergy were identified. Demographic data, medical history, and PSG findings of the included patients were analysed. The results of polysomnography (PSG) performed in our center showed that the incidence of obstructive sleep apnea syndrome (OSAS) in children with endocrinologic or respiratory diseases was higher (25.7% vs. 3%) and the mean age was older (7 years vs. 4 years) compared to the normal pediatric population. The prevalence of sleep disorders was similar in these patients and normal children (54.4% vs. >50%), as was the prevalence of central apnea (2.9%). There were no gender differences among patients with sleep disorders.

Anahtar Kelimeler

• Sleep Disorders
• Childhood
• Polysomnography
• Endocrinologic Disorders
• Respiratory Diseases

Kaynakça

1. 1. Carter KA, Hathaway NE, Lettieri CF. Common sleep disorders in children. American family physician 2014; 89(5):368–377.
2. 2. Khalsa S, Mayhew SD, Przezdzik I, Wilson R, Hale J, Goldstone A, et al. Variability in cumulative habitual sleep duration predicts waking functional connectivity. Sleep 2016; 39(1):87–95.
3. 3. Bathory E, Tomopoulos S. Sleep regulation, physiology and development, sleep duration and patterns, and sleep hygiene in infants, toddlers, and preschool-age children. Current problems in pediatric and adolescent health care 2017; 47(2):29–42.
4. 4. Rosenow F, McCARTHY V, Caruso A. Sleep apnoea in endocrine diseases. Journal of sleep research 1998; 7(1):3–11.
5. 5. Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest 1994; 105(1):151–154.
6. 6. Bixler EO, Vgontzas AN, Lin H-M, Liao D, Calhoun S, Vela-Bueno A, et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep 2009; 32(6):731–736.
7. 7. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children: associations with obesity, race, and respiratory problems. American journal of respiratory and critical care medicine 1999; 159(5):1527–1532.
8. 8. Given CA, 2nd, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol 2004; 182(1):195–199.

9. 9. Hutchison ER, Kawamoto EM, Taub DD, Lal A, Abdelmohsen K, Zhang Y, et al. Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia 2013; 61(7):1018–1028.
10. 10. Moturi S, Avis K. Assessment and treatment of common pediatric sleep disorders. Psychiatry (edgmont) 2010; 7(6):24.
11. 11. Chokroverty S. Overview of sleep & sleep disorders. Indian Journal of Medical Research 2010; 131(2):126–140.
12. 12. Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. The Journal of Clinical Endocrinology & Metabolism 2010; 95(2):483–495.
13. 13. Ww F. Clinical practice. Obstructive sleep apnea. N Engl J Med 2002; 347:498–504.
14. 14. Shelton KE, Woodson H, Gay S, Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 1993; 148(2):462–466.
15. 15. Carrera M, Barbe F, Sauleda J, Tomas M, Gomez C, Santos C, et al. Effects of obesity upon genioglossus structure and function in obstructive sleep apnoea. European Respiratory Journal 2004; 23(3):425–429.
16. 16. Grunstein R, Wilcox I, Yang T-S, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 1993; 17(9):533–540.
17. 17. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. The Journal of Clinical Endocrinology & Metabolism 2001; 86(2):517–520.
18. 18. Vgontzas AN. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Archives of physiology and biochemistry 2008; 114(4):211–223.
19. 19. Horton WA, Hall JG, Hecht JT. Achondroplasia. The Lancet 2007; 370(9582):162–172.
20. 20. Tasker RC, Dundas I, Laverty A, Fletcher M, Lane R, Stocks J. Distinct patterns of respiratory difficulty in young children with achondroplasia: a clinical, sleep, and lung function study. Archives of disease in childhood 1998; 79(2):99–108.
21. 21. Kamenicky P, Viengchareun S, Blanchard A, Meduri G, Zizzari P, Imbert-Teboul M, et al. Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology 2008; 149(7):3294–3305.
22. 22. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine reviews 2004; 25(1):102–152.
23. 23. Hernández-Gordillo D, del Rocío Ortega-Gómez M, Galicia-Polo L, Castorena-Maldonado A, Vergara-López A, Guillén-González MÁ, et al. Sleep apnea in patients with acromegaly. Frequency, characterization and positive pressure titration. The open respiratory medicine journal 2012; 6:28.
24. 24. Vannucci L, Luciani P, Gagliardi E, Paiano S, Duranti R, Forti G, et al. Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. Journal of endocrinological investigation 2013; 36:237–242.
25. 25. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. South African Family Practice 2012; 54(5):384–390.
26. 26. Deegan P, McNamara V, Morgan W. Goitre: a cause of obstructive sleep apnoea in euthyroid patients. European Respiratory Journal 1997; 10(2):500–502.
27. 27. Ehsan Z, Ishman SL, Kimball TR, Zhang N, Zou Y, Amin RS. Longitudinal cardiovascular outcomes of sleep disordered breathing in children: a meta-analysis and systematic review. Sleep 2017; 40(3):zsx015.
28. 28. Zhang W, Shen Y, Ou X, Wang H, Liu S. Sleep disordered breathing and neurobehavioral deficits in children and adolescents: a systematic review and meta-analysis. BMC pediatrics 2024; 24(1):70.
29. 29. Galland B, Spruyt K, Dawes P, McDowall PS, Elder D, Schaughency E. Sleep disordered breathing and academic performance: a meta-analysis. Pediatrics 2015; 136(4):e934–e946.
30. 30. Labanowski M, Schmidt-Nowara W, Guilleminault C. Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. Neurology 1996; 47(5):1173–1180.
31. 31. Culebras A. Sleep-disordered breathing in neuromuscular disease. Sleep Medicine Clinics 2008; 3(3):377–386.
32. 32. Marcus C, McColley S, Carroll J, Loughlin G, Smith P, Schwartz A. Upper airway collapsibility in children with obstructive sleep apnea syndrome. Journal of applied physiology 1994; 77(2):918–924.
33. 33. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008; 14(9):1157–1174.
34. 34. Naqvi SK, Sotelo C, Murry L, Simakajornboon N. Sleep architecture in children and adolescents with cystic fibrosis and the association with severity of lung disease. Sleep and Breathing 2008; 12:77–83.
35. 35. Bouka A, Tiede H, Liebich L, Dumitrascu R, Hecker C, Reichenberger F, et al. Quality of life in clinically stable adult cystic fibrosis out-patients: associations with daytime sleepiness and sleep quality. Respiratory medicine 2012; 106(9):1244–1249.
36. 36. Katz ES. Cystic fibrosis and sleep. Clinics in chest medicine 2014; 35(3):495–504.